Experiments suggest that simple plastic nanoparticles, delivered by IV, may be able to keep a type of immune cell — called a neutrophil — too busy to cause inflammation. Diseases in which neutrophils cause excessive inflammation include sepsis and atherosclerosis, or the hardening of the arteries.